About Us

Alto Predict helps biomedical researchers find and use human cell-based alternatives to animals (NAMs) to advance human-relevant science and make better decisions in drug discovery and product development.

  • We consult on the design and development of human disease-relevant cell models, managing projects with external CROs and academic collaborators. We have broad expertise across therapeutic areas and toxicity endpoints.  
  • We provide research data management support around data and documentation strategies, ELN organization, database design, metadata management, and AI-ready data.
  • We conduct project and program reviews to identify gaps and risks; advise on alternative approaches.

Alto Predict is also developing a registry (CHITA) of commercially available human in vitro NAMs to help researchers find and use these technologies. Our long term goal is to collect and integrate reference data from these assays for ingestion by AI agents to support better decision-making in drug discovery and product development. 

Leadership

Ellen Berg is a scientific leader specializing in human cell-based in vitro assays and platforms for drug discovery and chemical safety applications. Her expertise is in assay development, mechanisms of drug & disease biology, and the analysis & management of research data.

Dr. Berg has a background in biopharmaceutical research and drug discovery contract research services with startup, operations, and commercialization experience. Ellen led the development of BioSeek’s BioMAP® human primary cell-based profiling platform, now a commercial service of Eurofins Discovery.

Ellen is interested in mechanisms of human disease biology and drug action, predictive toxicology, and knowledge management methods (AI/ML approaches, knowledge graphs, ontologies and data visualization). She works with government and private organizations to promote FAIR data (Findable, Accessible, Interoperable and Reusable data) and the use of human-based NAMs in biomedical research and product development.

Connect with Ellen on LinkedIn.